KELLY MARCELLO: Open Payments
NPI 1699270462 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,527 in 128 payments from 21 companies in 2025. Trend: 2023 $230 · 2024 $9,213 · 2025 $13,527
Food & beverage: $5,420Travel & lodging: $3,107Speaker / faculty: $2,730Consulting: $2,170Education: $100
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 28 | $8,448 |
| Actelion Pharmaceuticals US, Inc. | 38 | $2,522 |
| United Therapeutics Corporation | 23 | $1,374 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Liquidia Technologies, Inc. | 2 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Vifor Pharma, Inc. | 2 | $65 |
| Baxter Healthcare | 3 | $60 |
| Grifols USA, LLC | 2 | $57 |
Products named: WINREVAIR, UPTRAVI, OPSUMIT, TYVASO, Adempas, YUTREPIA, OPSYNVI, OFEV.
Industry payments across AZ — which companies pay providers there.
